Granisetron Hydrochloride is the hydrochloride salt form of granisetron, enhancing its solubility for use in preventing chemotherapy-induced nausea and vomiting. It is grouped under the following drug class(es): Antiemetics and Serotonin agents. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include 1-methyl-N-((1R, 5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride and Kytril. Its PubChem CID is 49799997.
Granisetron hydrochloride
| CAS No | 107007-99-8 |
|---|---|
| Molecular Formula | C18H25ClN4O |
| Molecular Weight | 348.9 g/mol |
| Synonyms | 1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Granisetron Hydrochloride is the hydrochloride salt form of granisetron, enhancing its solubility for use in preventing chemotherapy-induced nausea and vomiting.
The listed CAS number is 107007-99-8.
The listed molecular formula is C18H25ClN4O.
The listed molecular weight is 348.9 g/mol.
1-methyl-N-[(1R,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride.
The source lists 1-methyl-N-((1R, 5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride and Kytril.